<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: Drug-refractory <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> in the setting of structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> results in frequent implantable cardioverter defibrillator therapies and an increased risk of <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Management requires catheter ablation procedures for effective suppression of the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>RECENT FINDINGS: Imaging and electroanatomic mapping technologies provide new insights into the myocardial structural abnormalities responsible for <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Integration of imaging data with three-dimensional mapping systems coupled with improved targeting of abnormal electrical signals may improve the ablation outcomes </plain></SENT>
<SENT sid="4" pm="."><plain>New ablation tools show promise for the effective ablation of previously unreachable myocardial <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> circuits </plain></SENT>
<SENT sid="5" pm="."><plain>SUMMARY: Catheter ablation procedures have evolved over the last 2 decades </plain></SENT>
<SENT sid="6" pm="."><plain>Improved technology may contribute to more widespread utilization of catheter ablation in the future </plain></SENT>
</text></document>